MedTrace Logo

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum

NCT02024581 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2019-04-16

No results posted yet for this study

Summary

This trial will examine the safety, tolerability and efficacy of one strength of East Indian sandalwood oil (EISO) in a cream base compared to a placebo for treatment of molluscum contagiosum in pediatric subjects. Trial participants will be asked to apply study medication twice a day for sixty (60) days. Efficacy will be evaluated by clinical staff and patients will be asked to assess tolerability as well as any improvement experienced during the trial.

Conditions

  • Molluscum Contagiosum

Interventions

DRUG

10% East Indian sandalwood oil cream

A topical oil/water emulsion cream containing 10% East Indian sandalwood oil (EISO)

DRUG

Placebo Cream

A sandalwood-scented oil/water emulsion topical cream matching the appearance of the active comparator creams

Sponsors & Collaborators

  • ViroXis Corporation

    lead INDUSTRY

Principal Investigators

  • John C. Browning, MD FAAD FAAP · Texas Dermatology and Laser Specialists

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-09-30
Completion
2017-09-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02024581 on ClinicalTrials.gov